T- and B-cell defects in a novel purine nucleoside phosphorylase mutation

Journal of Allergy and Clinical Immunology

Volumn 130, Issue 2, 2012, Pages 539-542

  Somech, Raz ^a,b   Lev, Atar ^a,b   Simon, Amos J ^a   Hanna, Suhair ^c   Etzioni, Amos ^c  

^a Edmond and Lily Safra Children's Hospital   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PURINE NUCLEOSIDE PHOSPHORYLASE; T LYMPHOCYTE RECEPTOR; URIC ACID;

APOPTOSIS; AUTOSOMAL RECESSIVE DISORDER; B CELL DEFECT; B CELL IMMUNODEFICIENCY; CELL MATURATION; CELLULAR IMMUNITY; CELLULAR IMMUNODEFICIENCY; CLINICAL FEATURE; CYTOMEGALOVIRUS; FLOW CYTOMETRY; GENE MUTATION; HEMOLYTIC ANEMIA; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LETTER; NEUTROPENIA; PRIORITY JOURNAL; PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY; T CELL DEFECT; THROMBOCYTOPENIA; THYROIDITIS; URIC ACID BLOOD LEVEL;

EID: 84864484168     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2012.03.038     Document Type: Article

References (14)

1. R. Hirschhorn Inherited enzyme deficiencies and immunodeficiency: adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNP) deficiencies Clin Immunol Immunopathol 40 1986 157 165
2. L.D. Notarangelo Primary immunodeficiencies (PIDs) presenting with cytopenias Hematology Am Soc Hematol Educ Program 2009 139 143
3. R. Hirschhorn, and F. Candotti Immunodeficiencies due to defects of purine metabolism H.D. Ochs, C.I.E. Smith, J.M. Puck, Primary immunodeficiency diseases 2nd ed. 2007 Oxford University Press 169 196
4. E. Grunebaum, J. Zhang, and C.M. Roifman Novel mutations and hot-spots in patients with purine nucleoside phosphorylase deficiency Nucleosides Nucleotides Nucleic Acids 23 2004 1411 1415
5. F. Serana, P. Airò, M. Chiarini, C. Zanotti, M. Scarsi, and M. Frassi Thymic and bone marrow output in patients with common variable immunodeficiency J Clin Immunol 31 2011 540 549
6. A. Sottini, C. Ghidini, C. Zanotti, M. Chiarini, L. Caimi, and A. Lanfranchi Simultaneous quantification of recent thymic T-cell and bone marrow B-cell emigrants in patients with primary immunodeficiency undergone to stem cell transplantation Clin Immunol 136 2010 217 227
7. A. Lev, A.J. Simon, M. Bareket, B. Bielorai, D. Hutt, and N. Amariglio The kinetics of early T and B cell immune recovery after bone marrow transplantation in RAG-2-deficient SCID patients PLoS One 7 2012 e30494
8. M.L. Markert, M.J. Alexieff, J. Li, M. Sarzotti, D.A. Ozaki, and B.H. Devlin Complete DiGeorge syndrome: development of rash, lymphadenopathy, and oligoclonal T cells in 5 cases J Allergy Clin Immunol 113 2004 734 741
9. T. Papinazath, W. Min, S. Sujiththa, A. Cohen, C. Ackerley, and C.M. Roifman Effects of purine nucleoside phosphorylase deficiency on thymocyte development J Allergy Clin Immunol 128 2011 854 863
10. I. Dalal, E. Grunebaum, A. Cohen, and C.M. Roifman Two novel mutations in a purine nucleoside phosphorylase (PNP)-deficient patient Clin Genet 59 2001 430 437
11. I. Homminga, C.M. Zwaan, C.Y. Manz, C. Parker, S. Bantia, and W.K. Smits In vitro efficacy of forodesine and nelarabine (ara-G) in pediatric leukemia Blood 118 2011 2184 2190
12. J.G. Scharenberg, L.J. Spaapen, G.T. Rijkers, M. Duran, G.E. Staal, and B.J. Zegers Functional and mechanistic studies on the toxicity of deoxyguanosine for the in vitro proliferation and differentiation of human peripheral blood B lymphocytes Eur J Immunol 16 1986 381 387
13. S. Bantia, C. Parker, R. Upshaw, A. Cunningham, P. Kotian, and J.M. Kilpatrick Potent orally bioavailable purine nucleoside phosphorylase inhibitor BCX-4208 induces apoptosis in B- and T-lymphocytes - a novel treatment approach for autoimmune diseases, organ transplantation and hematologic malignancies Int Immunopharmacol 10 2010 784 790
14. T. Robak, E. Lech-Maranda, A. Korycka, and E. Robak Purine nucleoside analogs as immunosuppressive and antineoplastic agents: mechanism of action and clinical activity Curr Med Chem 13 2006 3165 3189